Search PubMedSearch

PubMed · 7977423

Expert systems.

Abstract

The concept of computerized expert systems is explained, the potential utility of these systems in pharmacy is explored, and strategies and imperatives for implementing them are described. Computerized expert systems attempt a higher level of analysis than traditional computer programs. They can be defined as systems that attempt to make or assist in a decision that is not yet completely and reliably definable in objective terms. Because of the information-intensive nature of pharmacy practice, this field is particularly suited to use of expert systems. Current applications include screening for drug interactions and therapeutic drug monitoring. Expert systems must offer a substantial advantage over human expertise (for example, by quickly analyzing enormous quantities of data); those that perform functions that humans could perform have failed to gain widespread use. An ideal hospital expert system would have access to any data available about a patient's care and would detect critical situations as they occur. Such a system would require pharmacists to shift from a prescription-based orientation to a case-management orientation. Factors to consider in implementing an expert system include linkage among multiple departments, usage options, development strategies, and maintenance requirements. Computerized expert systems hold great potential for application to pharmacy and may influence the pharmacist's role in patient care.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Morrell, B Wasilauskas, R Winslow. 1994-08-15. Expert systems.. https://pubmed.ncbi.nlm.nih.gov/7977423/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Current and future risk assessment guidelines, policy, and methods development for chemical mixtures.

Humans are typically exposed to low doses of combinations of chemicals rather than to one or two chemicals at a time, yet most of the available toxicity data provide information on single chemicals or binary pairs, rather than on whole mixtures. The use of existing interactions study data for the quantitative risk assessment of chemical mixtures is problematic. These studies generally lack the necessary statistical characterizations to be useful in quantitative risk assessment procedures. The U.S. EPA developed guidelines for risk assessment for chemical mixtures in 1986 and is currently in the process of making revisions. Significant advances have been made in both the theoretical development and application of procedures such as dose addition, response addition, toxicity equivalence factors, comparative potency and interactions data characterizations. Details on the current revisions to the guidelines are given, along with information on the research efforts that have influenced these revisions or that represent future directions in chemical mixtures risk assessment.

Drug Interactions